153 related articles for article (PubMed ID: 19662512)
1. High resolution magnetic resonance imaging in atherosclerotic mice treated with ezetimibe.
Dietrich T; Hucko T; Bourayou R; Jahnke C; Paetsch I; Atrott K; Stawowy P; Gräfe M; Klein C; Schnackenburg B; Fleck E; Graf K
Int J Cardiovasc Imaging; 2009 Dec; 25(8):827-36. PubMed ID: 19662512
[TBL] [Abstract][Full Text] [Related]
2. Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis.
Graf K; Dietrich T; Tachezy M; Scholle FD; Licha K; Stawowy P; Grafe M; Hauff P; Fleck E
Mol Imaging; 2008; 7(2):68-76. PubMed ID: 18706289
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.
Davis HR; Compton DS; Hoos L; Tetzloff G
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2032-8. PubMed ID: 11742881
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice.
Braun A; Yesilaltay A; Acton S; Broschat KO; Krul ES; Napawan N; Stagliano N; Krieger M
Atherosclerosis; 2008 May; 198(1):77-84. PubMed ID: 18054357
[TBL] [Abstract][Full Text] [Related]
5. Effects of ezetimibe on atherosclerosis in preclinical models.
Davis HR; Lowe RS; Neff DR
Atherosclerosis; 2011 Apr; 215(2):266-78. PubMed ID: 21397230
[TBL] [Abstract][Full Text] [Related]
6. Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice.
Kuhlencordt PJ; Padmapriya P; Rützel S; Schödel J; Hu K; Schäfer A; Huang PL; Ertl G; Bauersachs J
Atherosclerosis; 2009 Jan; 202(1):48-57. PubMed ID: 18479686
[TBL] [Abstract][Full Text] [Related]
7. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
[TBL] [Abstract][Full Text] [Related]
8. Associations of ApoAI and ApoB-containing lipoproteins with AngII-induced abdominal aortic aneurysms in mice.
Liu J; Lu H; Howatt DA; Balakrishnan A; Moorleghen JJ; Sorci-Thomas M; Cassis LA; Daugherty A
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1826-34. PubMed ID: 26044581
[TBL] [Abstract][Full Text] [Related]
9. Pravastatin polarizes the phenotype of macrophages toward M2 and elevates serum cholesterol levels in apolipoprotein E knockout mice.
Zhang X; Xiao S; Li Q
J Int Med Res; 2018 Aug; 46(8):3365-3373. PubMed ID: 30058421
[TBL] [Abstract][Full Text] [Related]
10. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.
Trogan E; Fayad ZA; Itskovich VV; Aguinaldo JG; Mani V; Fallon JT; Chereshnev I; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1714-9. PubMed ID: 15256400
[TBL] [Abstract][Full Text] [Related]
11. Vascular protective effects of ezetimibe in ApoE-deficient mice.
Nakagami H; Osako MK; Takami Y; Hanayama R; Koriyama H; Mori M; Hayashi H; Shimizu H; Morishita R
Atherosclerosis; 2009 Mar; 203(1):51-8. PubMed ID: 18603252
[TBL] [Abstract][Full Text] [Related]
12. Relationship between hemodynamics and atherosclerosis in aortic arches of apolipoprotein E-null mice on 129S6/SvEvTac and C57BL/6J genetic backgrounds.
Tomita H; Hagaman J; Friedman MH; Maeda N
Atherosclerosis; 2012 Jan; 220(1):78-85. PubMed ID: 22078246
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D
Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733
[TBL] [Abstract][Full Text] [Related]
14. Rapid quantification of aortic lesions in apoE(-/-) mice.
Beattie JH; Duthie SJ; Kwun IS; Ha TY; Gordon MJ
J Vasc Res; 2009; 46(4):347-52. PubMed ID: 19142014
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
[TBL] [Abstract][Full Text] [Related]
16. MRI follow-up of TNF-dependent differential progression of atherosclerotic wall-thickening in mouse aortic arch from early to advanced stages.
Kober F; Canault M; Peiretti F; Mueller C; Kopp F; Alessi MC; Cozzone PJ; Nalbone G; Bernard M
Atherosclerosis; 2007 Dec; 195(2):e93-9. PubMed ID: 17662986
[TBL] [Abstract][Full Text] [Related]
17. [Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin II].
ZHAO R; YAO YY; DENG G; JU SH; WANG ZJ; WEN S; CHEN J; JIN H
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):823-8. PubMed ID: 21092653
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Antiatherogenic Properties of Ezetimibe Using
Dumas LS; Briand F; Clerc R; Brousseau E; Montemagno C; Ahmadi M; Bacot S; Soubies A; Perret P; Riou LM; Devoogdt N; Lahoutte T; Barone-Rochette G; Fagret D; Ghezzi C; Sulpice T; Broisat A
J Nucl Med; 2017 Jul; 58(7):1088-1093. PubMed ID: 28280218
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
